Sustanon (Testosterone)

Quick links to important sections

Sustanon (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sustanon (Testosterone)

Property Description
Active Ingredient Testosterone (as four distinct esters)
Form Oily Solution for Intramuscular Injection
Pharmacological Class Androgen (Anabolic-Androgenic Steroid)
General Purpose Hormone replacement and balance
Origin Synthetic derivative of a natural hormone

Sustanon (Testosterone) is a specialized, prescription-only medication classified pharmacologically as an Androgen (ATC code G03BA03). It functions as a synthetic derivative designed to replace or supplement the body's deficient production of the natural male sex hormone, testosterone. The drug is clinically recognized for its ability to manage systemic symptoms associated with insufficient testosterone levels in adult males.

This medication belongs to the family of Anabolic-Androgenic Steroids (AAS), where its core active substance is Testosterone. Its primary general purpose is hormone replacement, helping to restore hormonal balance in conditions of primary or secondary hypogonadism.


Sustanon's Unique Multi-Ester Composition and Form

Sustanon is defined by its structure as a combination medicine—specifically an oily solution for injection delivered via intramuscular injection. Its active composition includes four distinct testosterone esters: Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, and Testosterone Decanoate. This blend is designed to ensure a consistent hormonal level over time through its prolonged kinetic profile.

This multi-ester composition is expertly engineered for a staggered release profile, which is its key differentiating feature from single-ester androgen analogues. The varying ester chains are hydrolysed by the body into active testosterone at different rates, a process that creates a consistent and sustained release over a prolonged duration. The final preparation consists of these esterified compounds dissolved in an arachis oil base.

Regulatory References

  1. Testosterone: MedlinePlus Drug Information

What side effects are possible with Sustanon (Testosterone)?

Possible side effects and safety information

Regulatory documents classify the adverse reactions of testosterone products by the system-organ class affected and their reported frequency. These classifications reflect how government regulatory bodies organize and communicate the medicine’s safety profile.

Frequency-Classified Adverse Reactions

The most frequently documented effects are classified as common (affecting 1 to 10 users in 100), including polycythaemia (increase in red blood cell count), fluid retention (oedema), acne, and changes in the reproductive system such as increased Prostate Specific Antigen (PSA) and the development of gynaecomastia (breast enlargement). Uncommon effects (affecting 1 to 10 users in 1,000) may include hypertension, mood alterations (such as nervousness or aggression), and changes in libido.

Serious Adverse Reactions and Safety Constraints

Testosterone therapy is associated with warnings regarding serious events. The FDA label notes an increased risk of Venous Thromboembolism (VTE), including Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), as well as potential cardiovascular risks such as Myocardial Infarction (MI) and Stroke (CVA). Absolute prohibitions for use, or contraindications, include known or suspected Prostate Carcinoma and Male Breast Cancer.

Population-Specific and Duration-Related Safety

Safety constraints apply to specific populations. Use in older adults requires monitoring due to the increased risk of Benign Prostatic Hyperplasia (BPH) and prostatic changes. In pre-pubertal boys, use can cause premature epiphyseal closure, potentially resulting in growth limitation. Furthermore, the risk of developing polycythaemia and prostatic changes is linked to long-term exposure and necessitates mandatory, periodic monitoring of parameters like haematocrit, haemoglobin, and PSA throughout treatment, as defined in official regulatory texts.

Overdose and Emergency Response

Overdose of Sustanon (Testosterone) is generally not defined by acute toxicity but by chronic overexposure or abuse, leading to serious, dose-dependent adverse effects as documented in regulatory information. Signs of chronic over-treatment requiring medical evaluation include haematological abnormalities like polycythaemia (increased red blood cell count) and sexual effects such as priapism (frequent or prolonged, painful erections). Inappropriate virilisation has also been documented as a manifestation.

Chronic, high-dose exposure is associated with severe, potentially fatal outcomes affecting the cardiovascular system, including myocardial infarction (heart attack), stroke, and thromboembolic events. Immediate medical attention is required for any symptom consistent with a heart attack or stroke, such as chest pain, trouble breathing, or sudden weakness.

The regulatory guidance specifies that treatment should be discontinued if chronic over-treatment signs occur. If severe fluid retention (oedema) develops with or without congestive cardiac failure, treatment must be stopped immediately. For managing overdose, no specific antidote is known. The procedural measure involves drug discontinuation and providing appropriate symptomatic and supportive treatment. A population-specific consideration is that over-treatment in pre-pubertal boys can accelerate bone maturation, risking compromised adult stature.

Therapeutic Uses of Sustanon (Testosterone)

Understanding Sustanon

Sustanon is an injectable solution containing four different esters of testosterone. This specific formulation is designed to provide a steady release of the hormone into the bloodstream after administration. As a form of testosterone replacement therapy (TRT), its primary purpose is to restore testosterone levels in individuals where the body does not produce enough of the hormone naturally.

Main Uses

Testosterone Replacement Therapy (TRT)

The most common clinical use for Sustanon is the treatment of male hypogonadism. This condition occurs when the testes do not produce sufficient amounts of testosterone, which can be due to primary testicular failure or secondary issues related to the pituitary gland or hypothalamus. By providing a blend of short-acting and long-acting esters, Sustanon helps maintain consistent physiological levels of the hormone.

Gender-Affirming Care

In certain clinical settings, Sustanon is utilized as part of hormone therapy for transgender men. It assists in the development of secondary male characteristics, such as deepened voice, increased muscle mass, and changes in body fat distribution, helping to align physical appearance with gender identity.

Clinical Benefits

Restoration of Physical Vitality

When testosterone levels are normalized through treatment, patients often experience a significant reduction in fatigue and an increase in overall energy levels. It plays a crucial role in maintaining muscle mass and bone density, reducing the long-term risk of osteoporosis associated with hormone deficiency.

Improvement in Sexual Function

Low testosterone is frequently linked to a decrease in libido and erectile dysfunction. One of the primary benefits of treatment is the restoration of sexual desire and the improvement of sexual function and performance.

Mood and Cognitive Support

Testosterone deficiency can impact mental well-being, often manifesting as irritability, low mood, or difficulty concentrating. Stabilizing hormone levels can contribute to improved emotional stability, better mood regulation, and enhanced cognitive clarity.

Metabolic Health

Testosterone influences how the body manages insulin and fat. Maintenance of healthy hormone levels through therapy can assist in regulating body composition, specifically by decreasing visceral fat and supporting lean muscle maintenance.

Eligibility and Restrictions for Use

Official Eligibility for Sustanon (Testosterone) Use

Sustanon is a prescription-only medicine with use strictly governed by regulatory eligibility rules. It is primarily indicated for Adult Males with confirmed hormonal deficiency (hypogonadism). Eligibility for all other populations is severely restricted or absolutely prohibited.

Absolute Contraindications (Must Not Use)

Non-Eligible Population Condition/Restriction
Cancer Patients Known or suspected prostate cancer or male breast cancer.
Hypersensitivity Documented allergy to the active substance or excipients, including arachis oil (peanut oil).
Female Patients Pregnant or breastfeeding women.

Restricted and Conditional Use

Age-Specific: The drug is generally not recommended for children and adolescents due to the risk of premature epiphyseal closure (stunting growth). Use in older males is permitted but requires special monitoring for prostate health.

Comorbidity-Specific: Patients with severe cardiac, hepatic, or renal disease require extreme caution and close supervision. The treatment must be stopped immediately if the resulting fluid retention leads to complications like congestive heart failure.

Regulatory documentation defines these criteria to ensure appropriate and safe population-specific use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific interaction patterns for testosterone-containing products. Co-administration with other medicines may require close monitoring or dose adjustment based on the documented effects.


Pharmacodynamic and Exposure-Altering Interactions

Interacting Agent Category Documented Outcome Regulatory Constraint
Oral Anticoagulants (e.g., Warfarin) Enhanced anticoagulant action, increasing bleeding risk. Requires close monitoring of Prothrombin Time and INR.
Anti-diabetic Agents (e.g., Insulin) Improved glucose tolerance, potentially lowering blood glucose. May necessitate a decrease in the anti-diabetic dose.
Corticosteroids (or ACTH) Enhanced fluid retention (oedema formation). Use with special caution in patients with cardiac, renal, or hepatic disease.
Enzyme Modulators Enzyme-inducing/inhibiting agents can decrease or increase testosterone levels. Dose adjustment of testosterone may be necessary.

Other Documented Interactions and Constraints

Testosterone may cause a decrease in Thyroxine-binding Globulin (TBG) concentrations, altering total serum T4 measurements, though free thyroid hormone levels remain unchanged. The product is strictly contraindicated for use in patients with a known allergy to peanuts or soya, due to the presence of arachis oil (peanut oil) as an excipient in the oily solution.

Mechanism of Action

Sustanon, a combination of four testosterone esters, is designed to yield a sustained release profile, resulting in elevated circulating testosterone concentration. Testosterone works by passively diffusing across the cell membrane and binding to the androgen receptor (AR) within the cytoplasm. The activated AR then translocates to the nucleus to act as a transcription factor, regulating the transcription of specific genes. This action promotes protein synthesis, leading to increased nitrogen retention in muscle tissue. Increased testosterone levels facilitate the direct and indirect modulation of bone formation and resorption markers, promoting a positive shift in bone mineral balance. Androgen signaling influences neuronal pathways associated with central nervous system activity. The elevated androgen concentrations influence the hypothalamic-pituitary-adrenal (HPA) axis and subsequent feedback loops.

Dosage and Administration Information

How Sustanon (Testosterone) is Used: Official Administration Guidelines

Sustanon (Testosterone) is a specialized, long-acting medication defined by specific administration rules to ensure proper delivery and sustained hormonal release. These guidelines must be followed, as the medication is not intended for self-administration.


Official Administration and Dosing Protocol

Usage Aspect Official Regulatory Instruction
Route of Administration Must be given as a Deep Intramuscular (IM) Injection only. It is explicitly forbidden to administer the product intravenously.
Standard Dosing The typical dose for replacement therapy in adult males is 1 mL (which contains 250 mg of total testosterone esters) per injection.
Dosing Frequency The common maintenance schedule is one injection every 3 weeks. The specific interval and dose are subject to adjustment by the treating physician based on the patient's individual clinical response.
Administration Setting The injection must be performed only by a doctor or nurse or other trained healthcare professional. The injection should be delivered deeply into a muscle, such as the buttock or upper leg.
Timing and Preparation The injection can be given without regard to meals. The oily solution should not be refrigerated before use, as this can make the injection difficult.

Procedural and Population-Specific Rules

The treatment is typically considered long-term replacement therapy. If a dose is missed, a patient should not attempt to inject a double dose to compensate. The healthcare provider must manage the resumption of the treatment schedule. For specific populations, guidance notes that the treatment of pre-pubertal children must be approached with caution and requires careful medical monitoring. Any unused portion of the single-use ampoule must be discarded after injection.

Recent Clinical Evidence

Research evidence / Overview of studies for Sustanon (Testosterone)


Evidence for Use in Male Hypogonadism

The majority of formal clinical research on testosterone replacement therapy has been focused on adult males with confirmed symptomatic hypogonadism. This evidence base consists primarily of randomized controlled trials (RCTs), supplemented by meta-analyses and large observational studies. Research examined several core areas related to hypogonadism, including sexual function outcomes, body composition (lean mass versus fat mass), and bone mineral density (BMD). Studies monitored that the therapy's administration was associated with restoring serum testosterone concentrations to the normal physiological range in the observed populations. Research highlights changes measured for sexual function and body composition, where findings describe patterns observed in the studies.

What is still uncertain is the consistency of findings for some outcomes reflecting daily functioning or activity level. Studies focusing on endpoints like generalized vitality, mood, and physical function have provided mixed findings, and the evidence quality varies across studies.


Study Focus on Hormonal and Physiological Restoration

Research has explored the therapy's role in hormonal restoration itself. The evidence here is supported by clinical guidelines and expert consensus, which is informed by the physiological role of testosterone. Studies monitored the achievement and maintenance of serum testosterone levels within the required physiological range. Research describes that in appropriate populations, such as males with delayed puberty, studies observed the progression for male secondary characteristics in patients with a deficiency.


Evidence Quality and Research Gaps

The evidence quality varies across studies, with an evidence level of High assigned to outcomes related to normalizing hormone levels, changes in sexual function, and changes in lean body mass. However, for other outcomes, the certainty remains low because the findings were mixed or inconsistent across different trials. A significant research limitation frames the understanding of long-term safety and major clinical events. Follow-up durations were limited and sample sizes were modest in many key studies, meaning that long-term effects are not fully established for rare, but important, outcomes such as major cardiovascular events or fracture prevention.

Key Studies & References

  1. Testosterone Trials: Bone Density and Anemia Outcomes
  2. EMA's position statement: Testosterone replacement therapy in the aging male

Frequently Asked Questions (FAQ)

Common questions about Sustanon (Testosterone) (FAQ)


Q: How is Sustanon different from other testosterone injections like Test Cypionate or Enanthate?

A: Sustanon is unique because it is a combination of four different testosterone esters, unlike products that contain only a single ester. This multi-ester blend is pharmacologically designed to provide a staggered and sustained release profile, which is intended to maintain circulating testosterone levels over a prolonged period compared to single-ester preparations.


Q: Does Sustanon affect my cholesterol levels or liver function?

A: Official safety information reports that changes in lipid metabolism (cholesterol levels) and changes in liver function tests have been observed as potential side effects. Regulatory guidelines indicate that for individuals receiving long-term testosterone therapy, the monitoring of the lipid profile and liver function tests is generally required.


Q: What is the role of a healthcare professional in teaching proper injection technique for Sustanon?

A: Official product information notes that the medicine is administered by a healthcare professional. The prescribing physician may determine the need for instruction or training on correct use, particularly if self-administration is authorized.


Q: What is the shelf life of Sustanon vials or ampoules?

A: The unopened product typically has a shelf life of up to 5 years from the date of manufacture. The medicine must not be used after the expiry date printed on the packaging.


Q: How quickly does Sustanon start to show effects after the first injection?

A: Sustanon is formulated for a sustained effect, but the initial rise in testosterone levels is relatively rapid. According to pharmacokinetic studies, the concentration of testosterone in the blood typically reaches its peak within approximately 24 to 48 hours after the first injection.


Q: How long do the effects of a single Sustanon injection last in the body?

A: The multi-ester design allows the effects to last for several weeks. Official pharmacokinetic data shows that plasma testosterone levels generally return to the lower limit of the normal male range in about 21 days after a single injection. This duration informs the typical dosing interval established in official guidelines.


Q: Can Sustanon use cause changes in mood or increased aggression?

A: Official regulatory documents list mood alterations, including nervousness or increased aggression, as uncommon side effects. These changes, if experienced, would be discussed during regular medical review of the treatment.


Q: What happens if I forget to take my scheduled Sustanon injection?

A: If an injection is missed, the resumption of the treatment schedule would be managed by the treating healthcare professional. It is strictly advised that a person should not inject a double dose to try and compensate for the missed one.


Q: What are the potential long-term side effects of Sustanon use?

A: Long-term use requires monitoring for several risks, including polycythaemia (an increase in red blood cells) and prostatic changes, such as an increase in PSA (Prostate Specific Antigen) levels. Furthermore, the label notes potential serious risks, including venous thromboembolism and cardiovascular events.


Q: Does using Sustanon affect natural testosterone production?

A: Treatment with androgens like Sustanon can affect the body’s hormone system. This can lead to fertility disorders by repressing the natural formation of sperm (spermatogenesis), due to the negative feedback it exerts on the hormonal axis.


Q: How long does it takes for natural testosterone production to recover after stopping Sustanon?

A: The effects of Sustanon do not stop abruptly but gradually decrease after the medication is discontinued. Official patient information notes that the symptoms experienced before treatment may re-occur within a few weeks after the therapy is stopped.


Q: What is the maximum amount of time someone can safely be on Sustanon TRT?

A: The treatment is generally considered a long-term replacement therapy for chronic conditions. The need for continued treatment is generally subject to regular review by the prescribing physician, which includes an assessment of risks associated with long-term hormonal exposure.


Q: Can women be prescribed Sustanon for any medical conditions?

A: Sustanon is primarily indicated for adult males and is strictly contraindicated in pregnant or breastfeeding women. In other women, its use carries a risk of inducing virilisation (the development of male characteristics) such as hoarseness, acne, hirsutism, and menstrual irregularity.


Q: Is it normal to feel a temporary 'high' or energy surge right after a Sustanon injection?

A: A specific 'high' is not an officially listed symptom, but the medicine's pharmacological action leads to testosterone levels peaking soon after the injection. This peak concentration, occurring roughly 24 to 48 hours post-injection, may correlate with temporary changes in energy levels or mood.


Q: Why do some people report injection site pain or redness after a Sustanon shot?

A: Injection site reactions are listed as common adverse reactions associated with the use of the medicine. These reactions can include local pain, soreness, or erythema (redness) where the oily solution was administered deeply into the muscle.


Q: What is the role of the different esters in Sustanon (propionate, phenylpropionate, isocaproate, decanoate)?

A: The four different esters in Sustanon are designed to be broken down into active testosterone at different rates. The varying chain lengths create a staggered release profile, with some esters providing an initial rapid increase in testosterone and others providing a slower, sustained release over a longer period.


Q: Is Sustanon used for treating low testosterone in younger men with hypogonadism?

A: Sustanon is indicated for confirmed testosterone deficiency in adult males. While its use in pre-pubertal boys for delayed puberty is also noted, its primary indication is for hypogonadism in adults. Any use in younger individuals requires special caution due to risks like premature growth plate closure.


Q: How is Sustanon typically stored before it is used?

A: The medicine should be stored below 30 C and kept in its original packaging away from light. The medicine must not be refrigerated or frozen, as this may thicken the oily solution and affect its injectability.


Q: What should I do if the Sustanon injection solution looks cloudy or has particles?

A: Sustanon is meant to be a clear oily solution. If the ampoule appears cloudy, has visible particles, or shows any signs of deterioration, the product should not be used. If the solution appears to be deteriorated, it should not be used and would require proper disposal.


Q: How does a doctor monitor the effectiveness of Sustanon treatment?

A: A doctor monitors the treatment by periodically measuring serum testosterone levels to ensure they are within the normal physiological range. Additionally, they monitor various safety parameters, including hematocrit, hemoglobin, and Prostate Specific Antigen (PSA), at regular intervals throughout the course of therapy.


Q: Can I switch from a testosterone gel or patch to Sustanon injections?

A: Official regulatory documents do not provide a specific protocol for switching between different types of testosterone formulations. The decision to switch between a gel, patch, or injection, as well as the correct dose and schedule, must be determined by the treating physician based on individual clinical need.


Q: Does Sustanon require a post-cycle therapy (PCT) for long-term TRT?

A: Sustanon is approved for long-term testosterone replacement therapy (TRT), not for short-term 'cycles.' If a person stops treatment, their doctor will manage the cessation. The effects of the medicine wear off gradually, and pre-treatment symptoms may return within weeks.


Q: Can Sustanon be used to treat delayed puberty in boys?

A: Yes, the medicine is noted for use in males with delayed puberty. However, this application requires special caution and careful medical monitoring because of the risk of premature epiphyseal closure, which could potentially result in growth limitation.


Q: Does Sustanon interact with common over-the-counter pain relievers like ibuprofen?

A: Official regulatory documents detail specific interactions with categories of prescription drugs, such as oral anticoagulants and corticosteroids. The official label does not specifically list or warn against interactions with common over-the-counter pain relievers (NSAIDs) like ibuprofen.


Q: Can Sustanon be detected in drug tests, and for how long?

A: As a testosterone product, Sustanon can interfere with anti-doping tests. Patients involved in competitions governed by anti-doping organizations, such as the World Anti-Doping Agency (WADA), are advised to consult the relevant anti-doping codes before using the medication.


Q: Is it normal for energy levels to fluctuate between Sustanon injections?

A: The drug's kinetic profile causes hormone levels to rise to a peak and then gradually decline over the 3-week dosing interval before the next shot. This natural fluctuation in hormone levels over time may be linked to changes in a person’s generalized energy levels.


Q: Are there specific symptoms of low testosterone that Sustanon is most effective at treating?

A: Formal clinical research focusing on testosterone replacement therapy has consistently documented positive findings for sexual function outcomes, changes in body composition (such as increasing lean mass), and improvements in bone mineral density (BMD). These are the areas with the strongest evidence of treatment efficacy.


Q: Can Sustanon use lead to dependency or addiction?

A: Regulatory warnings indicate that testosterone abuse is associated with serious health problems. Individuals who have abused testosterone, especially when combined with other anabolic-androgenic steroids (AAS), may become dependent and could experience withdrawal symptoms if the treatment is stopped or significantly reduced.


Q: What should be done with unused or expired Sustanon medication?

A: Unused or expired Sustanon must be disposed of safely and in line with local requirements. The product should be disposed of in line with local requirements, typically by returning it to a pharmacist. It must not be discarded with household waste or flushed away.


Q: Can traveling across time zones affect the Sustanon injection schedule?

A: Sustanon is given in long intervals, typically every three weeks. While the drug's metabolism is not affected by time zones, the exact timing of the injection is determined by the physician, and any potential disruption to the schedule from travel would require medical consultation.

How should Sustanon (Testosterone) be stored and disposed of?

How to Store and Dispose of Sustanon (Testosterone)

Official regulatory information defines strict requirements for storing and disposing of the Sustanon oily solution for injection to maintain its stability and ensure safety.

Storage Requirements

  • Temperature: The medicine must be stored below 30 C (86°F).
  • Protection: The product must be kept in the original package to protect it from light.
  • Prohibited Environments: Regulatory labeling specifies that Sustanon must not be refrigerated or frozen.
  • Child Safety: The product must be stored out of the reach and sight of children.
  • Stability: The solution must be used immediately after the ampoule is opened and should not be used after the expiry date.

Disposal Instructions

  • Unused Product: Unused or expired Sustanon must be returned to a pharmacist for safe disposal.
  • Environmental Rule: The medicine must not be disposed of via household waste or flushed down the toilet/drain.
  • Sharps: All injection materials, including needles and syringes, must be disposed of in a proper sharps container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sustanon (Testosterone) found in:

A-Z Index: